BioSpace News Archive

Business

IDEXX Laboratories to Release 2023 Second Quarter Financial Results

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 second quarter results for Tuesday, August 1, 2023 before the market opens.

June 29, 2023
·
2 min read
Pharm Country

Acuitive Technologies Launches New Tendon Fixation Device for Sports Medicine

Acuitive Technologies, Inc. announced the first surgical use of its Citrelock® ACL Tendon Fixation Device.

June 29, 2023
·
2 min read
Business

Zymeworks Appoints New Director - June 29, 2023

Zymeworks Inc., a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, announced the appointment of Mr. Carlos E. Campoy to its board of directors effective as of June 30, 2023.

June 29, 2023
·
7 min read
Business

AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release

AmerisourceBergen Corporation announced that it plans to release its results for the Third Quarter of Fiscal 2023 on Wednesday, August 2, 2023, prior to the opening of trading on the New York Stock Exchange.

June 29, 2023
·
2 min read
Policy

FDA Approves First Gene Therapy for Adults with Severe Hemophilia A

The U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy for the treatment of adults with severe hemophilia A without pre-existing antibodies to adeno-associated virus serotype 5 detected by an FDA-approved test.

June 29, 2023
·
4 min read
Drug Development

SK bioscience-Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine Candidate

SK bioscience announced positive results from its Phase II clinical trials in infants of its 21-valent pneumococcal conjugate vaccine candidate, ‘GBP410', evaluating its safety and immunogenicity.

June 29, 2023
·
4 min read
Genetown

Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock

Black Diamond Therapeutics, Inc. announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a public offering price of $5.00 per share.

June 29, 2023
·
4 min read
FDA

FDA Approves ARUP Laboratories’ AAV5 DetectCDx™, a First-Ever Companion Diagnostic Immunoassay for a Gene Therapy

ARUP Laboratories announced that the U.S. Food and Drug Administration has approved AAV5 DetectCDx™ as a companion diagnostic to aid in the selection of adult patients eligible for treatment with ROCTAVIAN™.

June 29, 2023
·
5 min read
Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023

Bioheart, together with its holding subsidiary Angiocare announces the clinical result for Iberis-HTN at China Interventional Therapeutics 2023.

June 29, 2023
·
2 min read
Business

Enzolytics, Inc. Reports Amendment to Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp.

Enzolytics, Inc. announced today they have agreed to an amendment to the executed non-binding term sheet for the sale of Biogenysis, Inc. and Virogentics Inc.

June 29, 2023
·
5 min read